QuidelOrtho Eyes $1.5B Sale of COVID-Era Rapid Testing Business
The unit, once a pandemic star, attracts strong private equity interest.
/ 43 items
#XY News-Driven Stocks↓
Ardelyx Suffers Legal Setback as Appeals Court Confirms XPHOZAH in Medicare Bundle
Ardelyx shares fell after losing a court case on Xphozah Medicare coverage, moving drug into bundled payments, hurting revenue outlook.
Profit-Taking Hits Moderna Stock After mRNA-1010 Wins Unanimous FDA Panel Backing
Decision due Aug 5, 2026. Potential 2026–27 launch.
Butterfly Network Soars as Midjourney Enters Medical Imaging with Revolutionary Full-Body Ultrasound Scanner
AI-powered 60-second scans could transform preventive healthcare.
Edwards Lifesciences Gets Big Boost as CMS Expands TAVR Coverage to Asymptomatic Patients
TAVR is Edwards’ main business. New CMS rules could boost sales and help it take market share from Medtronic and Boston Scientific.
CMS Plans Permanent Medicare Drug Price Negotiations Starting 2029 – What It Means for Big Pharma
Medicare plans drug price cuts from 2029, hitting pharma stocks, but long-term impact may be limited by legal and market protections.